Skip to main content

Peer Review reports

From: Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study

Original Submission
2 Oct 2023 Submitted Original manuscript
9 Nov 2023 Reviewed Reviewer Report
11 Nov 2023 Reviewed Reviewer Report
20 Nov 2023 Author responded Author comments - Gen Lin
22 Nov 2023 Author responded Author comments - Gen Lin
Resubmission - Version 2
20 Nov 2023 Submitted Manuscript version 2
24 Nov 2023 Reviewed Reviewer Report
29 Nov 2023 Reviewed Reviewer Report
30 Nov 2023 Author responded Author comments - Gen Lin
Resubmission - Version 3
30 Nov 2023 Submitted Manuscript version 3
2 Dec 2023 Author responded Author comments - Gen Lin
Resubmission - Version 4
2 Dec 2023 Submitted Manuscript version 4
Publishing
10 Dec 2023 Editorially accepted
16 Dec 2023 Article published 10.1186/s12885-023-11737-x

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us